stella
beta
Nasal Decongestant to Reduce Perioperative Adverse Events in Children With Upper Respiratory Track Infections Having Anesthesia. — Stella
Recruiting
Back to Perioperative Respiratory Adverse Events trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
Australia
Perth Children's Hospital, Perth, We
View full record on ClinicalTrials.gov